Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1997
9-Aminocamptothecin: a topoisomerase I inhibitor with preclinical activity in prostate cancerP L de Souza, M R Cooper, A R Imondi, et al.
Cancer Chemotherapy and Pharmacology|January 29, 1999
Protection against doxorubicin-induced cardiotoxicity in weanling rats by dexrazoxaneP Della Torre, G Mazué, A Podestà, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Development of inhalational agents for oncologic useS Sharma, D White, A R Imondi, et al.
Cancer Chemotherapy and Pharmacology|July 21, 1999
Cardioprotection by dexrazoxane in rats treated with doxorubicin and paclitaxelP Della Torre, A R Imondi, C Bernardi, et al.
Cancer Chemotherapy and Pharmacology|May 11, 2001
PNU-159548, a novel cytotoxic antitumor agent with a low cardiotoxic potentialP Della Torre, A Podestà, A R Imondi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
Inhalation chemotherapy for macroscopic primary or metastatic lung tumors: proof of principle using dogs with spontaneously occurring tumors as a modelA E Hershey, I D Kurzman, L J Forrest, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
Topical delivery of 13-cis-retinoic acid by inhalation up-regulates expression of rodent lung but not liver retinoic acid receptorsD L Wang, M Marko, A R Dahl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
Inhaled isotretinoin (13-cis retinoic acid) is an effective lung cancer chemopreventive agent in A/J mice at low doses: a pilot studyA R Dahl, I M Grossi, D P Houchens, et al.
Pageof 4